Prospective characterization of musculoskeletal symptoms in early stage breast cancer patients treated with aromatase inhibitors

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Breast Cancer Research and Treatment

• Publication date

  2008-09-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s10549-007-9774-6PMID 17922185PMCID PMC3081690
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Switching to letrozole or exemestane improves hot flushes, mood and quality of life in tamoxifen intolerant women

  2008cited by this paper
• Aromatase inhibitor-associated arthralgia syndrome.

  2007cited by this paper
• Prevalence of joint symptoms in postmenopausal women taking aromatase inhibitors for early-stage breast cancer.

  2007cited by this paper
• Five years of letrozole compared with tamoxifen as initial adjuvant therapy for postmenopausal women with endocrine-responsive early breast cancer: update of study BIG 1-98.

  2007cited by this paper
• Survival and safety of exemestane versus tamoxifen after 2-3 years' tamoxifen treatment (Intergroup Exemestane Study): a randomised controlled trial.

  2007cited by this paper
• Debilitating musculoskeletal pain and stiffness with letrozole and exemestane: associated tenosynovial changes on magnetic resonance imaging

  2007cited by this paper
• The ne w e ngl and j our na l of medicine

  2006cited by this paper
• Joint symptoms: A practical problem of anastrozole

  2006cited by this paper
• Side effects of aromatase inhibitors versus tamoxifen: the patients' perspective.

  2006cited by this paper
• Comprehensive side-effect profile of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: long-term safety analysis of the ATAC trial.

  2006cited by this paper
• Expanding the definition of clinical differences: from minimally clinically important differences to really important differences. Analyses in 8931 patients with rheumatoid arthritis.

  2005cited by this paper
• Switching to anastrozole versus continued tamoxifen treatment of early breast cancer: preliminary results of the Italian Tamoxifen Anastrozole Trial.

  2005cited by this paper
• Aromatase inhibitors and the syndrome of arthralgias with estrogen deprivation.

  2005cited by this paper
• A randomized trial of exemestane after two to three years of tamoxifen therapy in postmenopausal women with primary breast cancer*

  2004cited by this paper
• A randomized trial of letrozole in postmenopausal women after five years of tamoxifen therapy for early-stage breast cancer.

  2004cited by this paper
• Aromatase-deficient mice spontaneously develop a lymphoproliferative autoimmune disease resembling Sjogren's syndrome.

  2004cited by this paper
• Rheumatic syndromes associated with malignancy

  2003cited by this paper
• An open randomised trial of second-line endocrine therapy in advanced breast cancer. comparison of the aromatase inhibitors letrozole and anastrozole.

  2003cited by this paper
• The Stanford Health Assessment Questionnaire: a review of its history, issues, progress, and documentation.

  2003cited by this paper
• American Society of Clinical Oncology technology assessment on the use of aromatase inhibitors as adjuvant therapy for postmenopausal women with hormone receptor-positive breast cancer: status report 2004.

  2002cited by this paper
• Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early breast cancer: first results of the ATAC randomised trial.

  2002cited by this paper
• Nodal metastasis is highly consistent in squamous cell carcinoma of the vulva.

  2001cited by this paper
• Aromatase inhibitors and arthralgia.

  2001cited by this paper
• Nodal metastasis is highly consistent in squamous cell carcinoma of the vulva.

  2001cited by this paper
• Rheumatic symptoms following adjuvant therapy for breast cancer.

  1997cited by this paper
• Postchemotherapy rheumatism following adjuvant therapy for ovarian cancer.

  1994cited by this paper
• The menopausal transition: a dynamic approach to the pathogenesis of neurovegetative complaints.

  1994cited by this paper
• Adverse effects of leuprolide acetate depot treatment.

  1993cited by this paper
• More postchemotherapy rheumatism.

  1993cited by this paper
• Postchemotherapy rheumatism.

  1993cited by this paper

• Low intensity vibration with zoledronate reduces musculoskeletal weakness and adiposity in estrogen deprived female mice

  2026cites this paper
• Aromatase Inhibitor-Induced Arthralgia Among Patients With Early Breast Cancer: Prevalence, Treatment Nonadherence, and Management in a Prospective Longitudinal Cohort.

  2026cites this paper
• Aerobic exercise and aromatase inhibitor–associated musculoskeletal symptoms: results of a randomized clinical trial

  2025cites this paper
• Patient-reported tolerance of 90 days of preoperative endocrine therapy: results from the preoperative window of endocrine therapy to inform radiation therapy decisions trial

  2025influential citation
• Aromatase inhibitor-induced musculoskeletal symptoms in foot and ankle surgery.

  2025cites this paper
• Neurosurgical Techniques for Chronic Pain in Adult Cancer Survivors

  2025cites this paper
• Aromatase Inhibitors as Adjuvant Therapy in Early Breast Cancer: Insights into Toxicities and Their Management

  2025cites this paper
• Critical role of the mast cell/tryptase/PAR2 axis in anastrozole-induced pain.

  2025cites this paper
• Pilot Study of Cannabidiol for Treatment of Aromatase Inhibitor‐Associated Musculoskeletal Symptoms in Breast Cancer

  2025cites this paper
• Treatment Modalities for Aromatase Inhibitor-Associated Musculoskeletal Syndrome (AIMSS): A Scoping Review of Prospective Treatment Studies

  2025cites this paper
• Aromatase Inhibitor-Induced Carpal Tunnel Syndrome Immunohistochemical Analysis and Clinical Evaluation: An Observational, Cross-Sectional, Case–Control Study

  2025cites this paper
• Estrogens produced within the central amygdala inhibit varicella zoster‐induced orofacial pain

  2025cites this paper
• Pain sensation and emotion induced by aromatase inhibitors: a new mouse model

  2025cites this paper
• Complex intervention including pain science education and patient-led goal setting-based self-management strategies for management of aromatase inhibitor-induced musculoskeletal symptoms: a single-arm feasibility and pilot study.

  2024cites this paper
• Local Synthesis of Estradiol in the Rostral Ventromedial Medulla Protects against Widespread Muscle Pain in Male Mice

  2024cites this paper
• Evidence-Based Guidance for Breast Cancer Survivorship

  2024cites this paper
• A Cohort Study to Evaluate Genetic Predictors for Aromatase Inhibitor Musculoskeletal Symptoms (AIMSS): Results from ECOG-ACRIN E1Z11.

  2024cites this paper
• Polypharmacy, over-the-counter medications, and aromatase inhibitor adherence in early-stage breast cancer

  2024cites this paper
• Aromatase Inhibitor-Associated Distal Radioulnar Joint Instability and Tear of the Extensor Digiti Minimi

  2024cites this paper
• Inflammatory Rheumatic Disorders as a Complication of Endocrine Therapy for Breast Cancer

  2024cites this paper
• A Randomized Controlled Trial of Hypnosis to Manage Musculoskeletal Pain in Breast Cancer Survivors Taking Aromatase Inhibitors.

  2024cites this paper
• A Study on the Application of Acupuncture in Alleviating Aromatase Inhibitor-Induced Joint Pain in Postmenopausal Breast Cancer Patients

  2024cites this paper
• Aromatase inhibitor-induced arthralgia ameliorated by Mediterranean diet and active lifestyle guided by continuous glucose monitoring: a case report and review of the literature

  2024cites this paper
• Association of Aromatase Inhibitor-Induced Musculoskeletal Symptoms with Central Sensitization-Related Symptoms: A Cross-Sectional Study

  2024influential citation
• The role of exercise in aromatase inhibitor‐induced arthralgia

  2024cites this paper
• Common Non-Rheumatic Medical Conditions Mimicking Fibromyalgia: A Simple Framework for Differential Diagnosis

  2024influential citation
• TRPV4 Activation and its Intracellular Modulation Mediated by Kinin Receptors Contribute to Painful Symptoms Induced by Anastrozole

  2023cites this paper
• Aromatase inhibitors: the journey from the state of the art to clinical open questions

  2023cites this paper
• Kinin B1 and B2 receptors mediate cancer pain associated with both the tumor and oncology therapy using aromatase inhibitors

  2023cites this paper
• Rheumatic aspects of arthralgias associated with aromatase inhibitor therapy (analysis of a clinical case series)

  2023cites this paper
• Whole Breast Irradiation in Comparison to Endocrine Therapy in Early Stage Breast Cancer—A Direct and Network Meta-Analysis of Published Randomized Trials

  2023cites this paper
• Assessing shoulder muscle stretch reflexes following breast cancer treatment and postmastectomy breast reconstruction.

  2023cites this paper
• Oxylipins as Biomarkers for Aromatase Inhibitor-Induced Arthralgia (AIA) in Breast Cancer Patients

  2023cites this paper
• Kinin B2 and B1 Receptors Activation Sensitize the TRPA1 Channel Contributing to Anastrozole-Induced Pain Symptoms

  2023influential citation
• Efficacy of Alternative Dose Regimens of Exemestane in Postmenopausal Women With Stage 0 to II Estrogen Receptor-Positive Breast Cancer: A Randomized Clinical Trial.

  2023cites this paper
• Feasibility of Symptom Monitoring During the First Year of Endocrine Therapy for Early Breast Cancer Using Patient-Reported Outcomes Collected via Smartphone App

  2023cites this paper
• Impact of CDK4/6 Inhibitors on Aromatase Inhibitor-Associated Musculoskeletal Syndrome (AIMSS) in the Adjuvant Setting

  2023cites this paper
• Variability of DNA Repair and Oxidative Stress Genes Associated with Worst Pain in Breast Cancer Survivors on Aromatase Inhibitors

  2023cites this paper
• Searching for Essential Genes and Targeted Drugs Common to Breast Cancer and Osteoarthritis.

  2023cites this paper
• Advances in the care of breast cancer survivors

  2023cites this paper
• Endocrine Therapy for Surgeons: Practical Pearls for Managing Menopausal, Bone Loss and Sexual Adverse Effects

  2023cites this paper
• Evidence-Based Guidance for Breast Cancer Survivorship.

  2023cites this paper
• Aromatase-Inhibitor-Induced Musculoskeletal Inflammation Is Observed Independent of Oophorectomy in a Novel Mouse Model

  2022cites this paper
• Comparison of the clinical effectiveness of treatments for aromatase inhibitor-induced arthralgia in breast cancer patients: A systematic review with network meta-analysis.

  2022cites this paper
• Feasibility Trial to Evaluate Tendon Stiffness Obtained from Shear Wave Elastography Imaging as a Biomarker of Aromatase Inhibitor-Induced Arthralgias

  2022cites this paper
• Musculoskeletal Pain and the Prevalence of Rheumatoid Arthritis in Breast Cancer Patients During Cancer Treatment: A Retrospective Study

  2022cites this paper
• Feasibility of a Supervised Virtual Exercise Program for Women on Hormone Therapy for Breast Cancer

  2022cites this paper
• Strategies to mitigate the toxicity of cancer therapeutics.

  2022cites this paper
• Aromatase Inhibitor–Induced Carpal Tunnel Syndrome and Stenosing Tenosynovitis: A Systematic Review

  2022cites this paper
• Aromatase inhibitor–associated musculoskeletal pain: An overview of pathophysiology and treatment modalities

  2022cites this paper
• Carpal tunnel syndrome and tenosynovitis in women with breast cancer associated with hormone therapy

  2022cites this paper
• Maintaining functional status among older adult cancer patients and survivors

  2022cites this paper
• Systemic therapies for preventing or treating aromatase inhibitor-induced musculoskeletal symptoms in early breast cancer.

  2022cites this paper
• Sulindac Improves Stiffness and Quality of Life in Women Taking Aromatase Inhibitors for Breast Cancer

  2022cites this paper
• Baduanjin’s impact on quality of life and sleep quality in breast cancer survivors receiving aromatase inhibitor therapy: a randomized controlled trial

  2022cites this paper
• Aromatase Inhibitor Induced Musculoskeletal Inflammation is Observed Independent of Oophorectomy in a Novel Mouse Model

  2022cites this paper
• Current understanding of the diagnosis and management of the tendinopathy: An update from the lab to the clinical practice.

  2022cites this paper
• Aromatase Inhibitor Musculoskeletal Syndrome

  2021cites this paper
• Shear wave elastography detects novel imaging biomarkers of aromatase inhibitor–induced joint pain: a pilot study

  2021cites this paper
• A new clinically-relevant rat model of letrozole-induced chronic nociceptive disorders.

  2021influential citation
• CDK4/6 Inhibitors and Arthralgia: A Single Institution Experience

  2021cites this paper
• Aromatase and CDK4/6 Inhibitor-Induced Musculoskeletal Symptoms: A Systematic Review

  2021influential citation
• Aromatase Inhibitor-induced Musculoskeletal Syndrome: a Review of Rehabilitation Interventions

  2021cites this paper
• Aromatase Inhibitor-Associated Musculoskeletal Syndrome: Understanding Mechanisms and Management

  2021cites this paper
• Pain in the Cancer Survivor.

  2021cites this paper
• Aromatase Inhibitors—Induced Musculoskeletal Disorders: Current Knowledge on Clinical and Molecular Aspects

  2020cites this paper
• Extended Endocrine Therapy for Early-Stage Breast Cancer: How Do We Decide?

  2020cites this paper
• Cancer Rehabilitation:: Acute and Chronic Issues, Nerve Injury, Radiation Sequelae, Surgical and Chemo-Related, Part 2.

  2020cites this paper
• The Effects of Pharmacological and Non-Pharmacological Interventions on Symptom Management and Quality of Life among Breast Cancer Survivors Undergoing Adjuvant Endocrine Therapy: A Systematic Review

  2020cites this paper
• A randomized, double-blind, placebo-controlled trial of testosterone for treatment of postmenopausal women with aromatase inhibitor-induced arthralgias: Alliance study A221102

  2020cites this paper
• Rheumatological Findings in Patients with Breast Cancer.

  2020cites this paper
• Association of CYP19A1 gene variations with adjuvant letrozole-induced adverse events in South Indian postmenopausal breast cancer cohort expressing hormone-receptor positivity

  2020cites this paper
• Management of hormone receptor-positive, HER2-negative early breast cancer.

  2020cites this paper
• Management of Aromatase Inhibitor-Induced Musculoskeletal Symptoms.

  2020cites this paper
• Sex Differences in Estradiol Secretion by Trigeminal Brainstem Neurons

  2019cites this paper
• Effects of SLCO1B1 polymorphisms on plasma estrogen concentrations in women with breast cancer receiving aromatase inhibitors exemestane and letrozole.

  2019cites this paper
• Longer Times of Receipt of Adjuvant Endocrine Therapy Correspond to Improved Functional Capacity and Lower Adiposity in Women Receiving Adjuvant Therapy

  2019cites this paper
• Higher symptom burden is associated with lower function in women taking adjuvant endocrine therapy for breast cancer.

  2019cites this paper
• Prospective evaluation of finger two-point discrimination and carpal tunnel syndrome among women with breast cancer receiving adjuvant aromatase inhibitor therapy

  2019cites this paper
• A phase II study evaluating the efficacy of zoledronic acid in prevention of aromatase inhibitor-associated musculoskeletal symptoms: the ZAP trial

  2018influential citation
• Single arm phase II study of oral vitamin B12 for the treatment of musculoskeletal symptoms associated with aromatase inhibitors in women with early stage breast cancer

  2018cites this paper
• A combination of hydroxytyrosol, omega-3 fatty acids and curcumin improves pain and inflammation among early stage breast cancer patients receiving adjuvant hormonal therapy: results of a pilot study

  2018cites this paper
• Randomized placebo-controlled pilot trial of omega 3 fatty acids for prevention of aromatase inhibitor-induced musculoskeletal pain

  2018cites this paper
• Aromatase Derived Estradiol Within the Thalamus Modulates Pain Induced by Varicella Zoster Virus

  2018cites this paper
• Osteoporosis and musculoskeletal complications related to therapy of breast cancer.

  2018cites this paper
• Aging Perceptions and Non-Adherence to Aromatase Inhibitors among Breast Cancer Survivors

  2018cites this paper
• Vitamin D Levels, Vitamin D Receptor Polymorphisms, and Inflammatory Cytokines in Aromatase Inhibitor‐Induced Arthralgias: An Analysis of CCTG MA.27

  2018cites this paper
• Multidisciplinary Approach for Bone Metastasis: A Review

  2018cites this paper
• Use of a web-based app to improve breast cancer symptom management and adherence for aromatase inhibitors: a randomized controlled feasibility trial

  2018cites this paper
• Ageing perceptions and non-adherence to aromatase inhibitors among breast cancer survivors.

  2018cites this paper
• Efficacy of Complementary Therapies in the Quality of Life of Breast Cancer Survivors

  2018influential citation
• Genomic risk prediction of aromatase inhibitor‐related arthralgia in patients with breast cancer using a novel machine‐learning algorithm

  2017influential citation
• Genetic analysis of steroid pathway enzymes associated with adverse musculoskeletal effects of aromatase inhibitors

  2017cites this paper
• Rehabilitation Strategies and Outcomes of the Sarcoma Patient.

  2017cites this paper
• Quality of life and impact of pain in women treated with aromatase inhibitors for breast cancer. A multicenter cohort study

  2017cites this paper
• Characterization and pharmacogenetics of hepatic phase I exemestane metabolism

  2017cites this paper
• The Garvan calculator and fragility fracture risk

  2017cites this paper
• Bidirectional Text Messaging to Monitor Endocrine Therapy Adherence and Patient-Reported Outcomes in Breast Cancer.

  2017cites this paper
• THU0060 T cell-derived IL-17A and IL-17F drive bone formation from human periosteal stem cells: implications for enthesophyte formation

  2017cites this paper
• Interventions for the Treatment of Aromatase Inhibitor–Associated Arthralgia in Breast Cancer Survivors: A Systematic Review and Meta-analysis

  2017cites this paper